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Hybrid nanomaterials possessing dual magnetic/optical properties are of 
considerable interest to many areas, ranging from material science to medicine and 
biology.  They are promising for a broad range of applications including catalysis, energy 
conversion, biological separation, medical diagnosis and treatment. Anisotropic 
magnetic-optical nanoparticles give better or new properties compared to spherical ones 
due to their high curvature and polarization-sensitive geometry. However, the 
engineering of compact and uniform anisotropic magnetic-optical core-shell 
nanoparticles remains a major challenge.  The work of this thesis is aimed at the 
preparation and characterization of magnetic-optical core-shell hybrid NPs in different 
shapes and sizes.  Iron oxide-gold core-shell nanoparticles in spherical, oval and pin 
shapes were prepared.  Our studies have shown that iron oxide-gold core-shell 
nanoparticles, despite the shapes, exhibit 10 times better absorption properties compared 
to solid gold nanoparticles. The availability of these nanoparticles would make an 










 The majority of the work from this thesis is written based on a journal article 
entitled, “Synthesis and properties of near infrared-absorbing magnetic–optical 
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CHAPTER 1. INTRODUCTION 
1.1. Background  
 The word nano, derived from the Greek nanos, meaning "dwarf", is used to 
describe any material or property having dimensions on the nanometer scale (1-100 nm). 
Nanoparticles (NPs) are all around us in nature and  have been around forever, but only 
over the last few decades have the experimental methods become available which allow 
chemists to synthesize nanomaterials in a controlled and reproducible way.
1
 These 
nanomaterials, behave significantly differently than bulk materials due to their unique 
surface and quantum confinement effects.
2
  These NPs display different physical and 
chemical properties which have made them a major focus of research over the past 
decade.  One major application of the use of NPs is in biomedicine.  A few of the major 
classes of NPs used for biomedical applications are magnetic and gold NPs. 
1.2. Magnetic nanoparticles 
 Magnetic nanoparticles (NPs) are being used in an increasing number of medical 
applications. Some important properties of magnetic NPs that contribute to their medical 
applications include nontoxicity, biocompatibility, and high-level accumulation in the 
target tissue. Iron oxide (IO), Magnetite, (Fe3O4) and Maghemite (Fe2O3), are the most 
widely used materials due to their biocompatibility and ease of synthesis in a suitable size 
range for biomedical applications.
3
 Magnetite is of particular interest due to its proven 
biocompatibility. Superparamagnetic nanoparticles do not exhibit a magnetic response in 
the absence of an external magnetic field. For magnetic-related biomedical applications, 
the nanoparticles should be superparamagnetic to avoid magnetization residue-induced 
aggregation.
3
  It is well known that the magnetic property of iron oxide nanoparticles is 
2 
 
size dependent.  Fe3O4 nanoparticles are typically superparamagnetic at ≤ 30 nm, with 
larger sizes displaying ferromagnetic properties. Also magnetic nanoparticles less than 4 
nm in size are typically not responsive enough to an external magnetic field for  
magnetophoretic motion in real time.
4
  It is also advantageous for the nanoparticles to 
have similar dimensions to that of proteins (5-50 nm), viruses (20-500 nm), genes (2-100 
nm), and other biological molecules for use in bio-applications.
4
 
 IO NPs have been synthesized by a variety of methods including co-precipitation, 
thermal decomposition, microemulsion, and hydrothermal synthesis. In many methods it 
is difficult to control the size. The co-precipitation method usually leads to polydispersed 




 IO NPs have been widely used for cell magnetic separation, T2-weighted 
magnetic resonance imaging (MRI), drug delivery, and  hyperthermia treatment due to 
their unique responses to magnetic force.
4
 Magnetic separation using IO NPs has been 
widely used in most areas of biosciences and biotechnology for separations of chemical 
and bimolecular molecules, biological cells and pathogens. IO NPs have been used for 
separation of rare cancer cells in the blood.
6
 In fact, the CellSearch system, the only 
technique approved by U.S. Food and Drug Administration (FDA) for clinical utilization, 
uses magnetic beads with the anti-epithelial cell adhesion molecules (anti-EpCAM) 
antibodies to separate and enrich circulating tumor cells (CTCs) with the use of external 
permanent magnets.
7
  Cell labeling with IO NPs has also been commonly used for MRI. 
The most common labeling technique is directly attaching IO NPs to the cell surface by 
specific binding of the NPs to the cells. Attaching a ligand that is specific to the target 
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cell allows for efficient cell uptake via receptor-mediated endocytosis. A variety of 
potential ligands have been successfully used to facilitate receptor-mediated endocytosis 
of conjugated NPs, including monoclonal antibodies (Mabs). Antibody-antigen binding 
provides a highly accurate method for cell labeling. Cell targeting can be achieved with 
targeting ligands such as growth factors, insulin, albumin, lactoferrin and transferrin 
because the receptors for these ligands are usually overexpressed on the surface of 
malignant cells. Most of these ligands are stable and thus ideal for bioconjugation to 
targeted cells. IO NPs can also be used in immunoassays, which are commonly used for 
medical examinations in detection of viruses or an assay of various hormones. The 
magnetic separation can greatly reduce the duration of separation steps and therefore save 
time.      
 MRI is currently one of the most important imaging modalities in clinical settings. 
MRI offers high spatial resolution. MRI is based on nuclear magnetic resonance (NMR) 
signal of protons under a strong static magnetic field. MRI relies on the minute amount  
of magnetic moment on a proton and the very large number of protons present in 
biological tissue, which allows a measurable amount in the presence of a strong magnetic 
field.
4
  A radio frequency transverse field is applied in a pulsed manner.  This causes the 
nuclei to produce a rotating magnetic field detectable by the scanner and this information 
is recorded to construct an image of the scanned area of the body. Superparamagnetic 
NPs are known to be effective contrast agents in clinical settings. These NPs reduce the 
signal of T2-weighted images which lowers negative contrast.
8
  IO NPs have also shown 
the ability to detect apoptosis and self-destruction of cells by MRI.
9
  IO NPs conjugated 





 Suziki et al. specifically conjugated Fe3O4 NPs to monoclonal antibodies 
(MAbs) for active targeting to cancer cells. They first conjugated poly-ethylene glycol 
(PEG)-coated Fe3O4 NPs to a MAb that was specific to a human glioma cell surface 
antigen. They then injected the particles intravenously into nude mice with tumors. The 
IO NPs accumulated into the tumor tissue after 24 hours. A 50% decrease in the T2 
signal intensity of the tumor was observed.
11
 This demonstrated that IO NPs could be 
used as great contrast agents for enhancing MR imaging. 
 Hyperthermia, the elevation of localized tissue temperature, is a promising 
approach to cancer therapy. Hyperthermia treatment is a usually used in supplement with 
chemotherapy, radiotherapy, and surgery in cancer therapy. In hyperthermia treatment, 
the temperature of the tissue is heated to 43 - 44
o
C. But, higher temperatures will have a 
greater "kill rate" of tumor cells. The major challenge of hyperthermia treatment is the 
difficulty of heating the localized tumor cells without damaging the surrounding tissue. 
IO NPs have been one of the major contrast agents for inducing hyperthermia.
12
 In the 
presence of an alternating magnetic field (AMF), the NPs are heated. The rotation in the 
magnetic vector of the particle, Neel Relaxation, is the dominant mechanism of heating.
12
  
Therefore in an AMF when the dipoles are rapidly rotating back and forth congruently 
with the magnetic field, it creates a "magnetic friction" which generates heat. The size 
and the shape of the IO NPs play an important role in the heating.  Jordan and co-workers  
successfully demonstrated the use of superparamagnetic IO NPs in hyperthermia of brain 
tumors.
13
 They directly injected the particles into tumors of human patients. The particles 
were then heated by an external AMF. The maximum temperature reached within the 
tumor was between 42.4 and 49.5
 o





  Clinical studies performed so far have shown that interstitial brain 
hyperthermia is feasible with the use of IO NPs and the toxicity is acceptable if the 
heating and target volume is carefully monitored.    
 Drug delivery is also a promising application of magnetic NPs. The NPs can be 
used as drug carriers for site-specific delivery.  The surface chemistry, size, and charge of 
the NPs are very important for delivery into the blood and biocompatibility of the 
particles.
3
  Internalization is strongly dependent on the size and magnetic properties of 
the particles.  Larger particles greater than 200 nm are typically separated by the spleen 
and removed by the cells of the reticuloendothelial system, RES.
15
 Particles less than 10 
nm are rapidly removed by renal clearance. Therefore, NPs with sizes from 10 to 100 nm 
show the most prolonged blood circulation times. When the NPs aggregate they tend to 
adsorb plasma proteins which are in turn taken up by the RES due to their hydrophobic 
surface. Therefore it is advantageous to coat the particles with an amphiphilic polymer 
such as PEG. PEG significantly increases the blood circulation time by minimizing 
protein adsorption to the NPs.
16
  It has been shown that PEG modified IO NPs showed a 
higher cell uptake in breast cancer (BT20) cells due to PEG high solubility in cell 
membranes.
17
  Once the drug loaded NPs are injected, they can be guided under a 
localized magnetic field and used for therapy.  IO NPs were used for the first time in 
animal studies by Lubbe et al.
18
  They were also tested in cancer patients.
18
 In the studies 
on cancer patients, epirubicine was attached to the particles via electrostatic interactions. 
Epirubicine was effectively targeted to the tumor site in 6 patients. The particles inside 
the liver appeared to produce no toxic effects.
18
  Fe3O4 particles have been used to deliver 
cytotoxic drugs to osteosarcoma sites directed by permanent magnets. The NPs showed a 
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four-fold increase in drug delivery to the tumor site and a significant increase in anti-




 Although there are many advantages to magnetic NPs at present, there are still 
limitations.  Despite the great resolution of MRI, it is not as sensitive as optical imaging. 
Magnetic NPs do possess the ability to generate heat which can be used for hyperthermia 
treatment, but they typically can only reach temperatures near 40
o
C unless a very high 
power source is used. Magnetic NPs also have limited capabilities in spectroscopic 
detection due to their inability to absorb light. 
1.3. Metallic Nanoparticles 
 Metallic (plasmonic) NPs are made of noble metals and exhibit special surface 
plasmon resonance (SPR), a photophysical phenomenon leading to strongly enhanced 
radiative (e.g. absorption and scattering) and nonradiative photothermal properties. For 
biomedical purposes, Au NPs are popular metallic NPs. There have been an extensive 
amount of studies done on the toxicity of Au NPs and the general conclusion from these 
studies is that Au NPs are biologically inert, and non-toxic.
20-25
  Au NPs have been used 
in biomedical applications since their first colloidal syntheses more than three centuries 
ago.  Unlike bulk or molecular-scale gold, nanoscale gold exhibits vivid colors which 
have made them widely popular objects of study for chemists, physicists, and now 





Figure 1.1. Gold nanoparticles commonly used in biomedical applications.
20 
 
 What makes these metallic NPs unique is their interaction with incident light.  In 
the presence of the oscillating electromagnetic field of light, the conduction band 
electrons of a metal nanoparticle undergo a collective coherent oscillation in resonance 
with the frequency of incident light leading to constructive interferences, which is called 
the SPR effect.
20
  As a result of the SPR oscillation, all radiative properties, such as light 
absorption, fluorescence, Rayleigh (Mie) scattering, and Raman scattering are enhanced 
by orders of magnitude.
26
  Different geometries of Au NPs display different optical 
properties. The SPR effect is dependent on the particle size, shape, structure, the 
dielectric properties of the metal, and the surrounding medium, as all of these factors 
affect the electron charge density on the particle surface.
20
 
 Currently most colloidal methods for synthesizing Au NPs use a gold salt which 
is reduced in the presence of surface capping ligands that prevent aggregation and 
stabilize the particles by electrostatic and/or physical repulsion. Particle size is easily 
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tunable by varying the gold ion/reducing agent or gold ion/surfactant ratio, with larger 
(and typically less monodisperse) sizes obtained from larger ratios.
20
   
 The intriguing properties of Au NPs have led to a wide variety of biomedical 
applications including optical bio-imaging, spectroscopic detection, bio-sensing, and 
photothermal therapy.
27-32
 The strong scattering from these Au NPs greatly increases 
their functionality in optical imaging. Furthermore, the optical imaging resolving power 
using these NPs has greatly increased.  Dark-field microscopy remains one of the most 
popular  bio-imaging methods using Au NPs.
26
  In dark-field microscopy, the light 
entering the objective lens is only the light scattered by the object at side lighting (similar 
to the Tyndall effect); therefore, the scattering object looks bright against a dark 
background.  Compared with fluorescent labels, Au NPs have a much greater potential to 
reveal bio-specific interactions with the use of dark-field microscopy, because the particle 
scattering cross section is three to five orders of magnitude greater than the fluorescence 
cross section for a single molecule.
33
 This principle was demonstrated for the first time 
by Mostafa El-Sayed’s group, which conjugated Au NPs with a tumor-antigen specific 
antibodies to the cancer cell surface.
34
 They then used dark-field microscopy to image 
cancer cells after incubated with antibody-conjugated Au NPs (Figure 1.2).
34
  With dark-
field microscopy it becomes possible to ‘‘map out’’ a tumor with an accuracy of several 





Figure 1.2. Dark-field microscopy of HaCat healthy cells (a) and HSC-3 cancerous (b) 
cells by using Au NPs conjugated with anti-epidermal growth factor antibodies. The 




Other successful methods of bio-imaging using Au NPs include optical coherence 
tomography,
35
 X-ray and magnetic resonance tomography,
36
 photoacoustic microscopy 
and tomography,
37
 fluorescence correlation microscopy,
38
 among other techniques. These 
methods also successfully use various sized and shaped gold nanoparticles. The strong 
light scattering properties of gold nanoparticles allow them to be a very useful qualitative 
tool in bio-imaging. 
 Due to the strong surface electromagnetic fields that propagate around metallic 
NPs, molecules in close proximity to the surface of these NPs can also exhibit different 
properties.  An example of this plasmonic near-field effect is the large enhancement of 
the Raman scattering by species adsorbed onto the surface of the NPs known as surface-
enhanced Raman scattering (SERS).
39
  SERS is known to be an ultrasensitive, down to 
single particle and single molecule level.
40
  It results in sharp fingerprint-like signals 
which are distinct from other interferences within the complex biological milieu.
39
  Au 
NPs are desirable substrates for SERS-based biomedical detection because of their facile 







delocalized pi electrons) are adsorbed or covalently conjugated to the NPs.  This results 
in a strong SERS signal that is specific to the attached Raman reporter.  This is a highly 
specific method because it avoids signal interferences from competing species due to the 
finger-print features of SERS signals. The enhancement of the Raman signal can be as 
high as 10
14
 therefore proving to be very advantageous in ultra-sensitive assays.
40
  Raman 
reporters have been used to detect biomarkers in cancer, viral and bacterial 
microorganisms and other diseases.
41-43
  Raman reporters have recently been used as a 
tool for the detection of CTCs.
44
  Wang et al. reported that epidermal growth factor 
(EGF)-conjugated, SERS-tagged Au NPs can detect CTCs in mice and human blood 
samples.
44
  Their Raman reporters showed high specificity to head and neck cancer cells 
in a sea of white blood cells with a sensitivity threshold of 5–50 cells per mL blood.
44
 
Compared to fluorescence detection, this SERS approach is advantageous because the 
signals are much sharper and distinct from complex biological fluids therefore 
minimizing effects from biological background fluorescence.
45
 
 Photothermal therapy is currently one of the most promising research applications 
in the treatment of cancer and other diseases.
26
  When metallic NPs are exposed to laser 
light in resonance with their surface plasmon oscillation, they have the ability to strongly 
absorb the light and rapidly convert it into heat via a series of photophysical processes.
20
  
Current gold-based NPs for photothermal cancer therapy are nanospheres, nanorods, 
nanoshells, and nanocages.
46
  Gold nanospheres do not absorb light in the near-infrared 
(NIR) window (650-900 nm), whereas nanorods, nanoshells, and nanocages have strong 
NIR absorption.
47
 Light penetration is optimal in the NIR window due to minimal 
absorption by water and hemoglobin in the tissue.
39
 Thus, the gold nanorods, nanoshells, 
11 
 
and nanocages are very promising for photothermal cancer therapy. Au NPs have the 









higher solubility, efficient absorption in NIR window, and facile conjugation with 
targeting molecules and drugs. These properties make Au NPs the most promising 
candidates for photothermal therapy of cancer and various pathogenic diseases.
20
  
Currently, there are many publications describing Au NPs for photothermal ablation of 
cancer cells and various other diseases.
20,39
  El-Sayed et al. first demonstrated the use of 
gold nanorods for in vivo photothermal therapy in 2008, showing that the method was 
able to significantly inhibit tumor growth following a single 10 minute laser exposure 
experiment.
49
  Gold nanorods have also been shown to ablate tumors in mouse models of 
colon cancer and squamous cell carcinoma.
49
  Xia et al. used targeted nanocages 
approximately 45 nm in length and with plasmonic absorption maxima at 810 nm, to 
ablate SK-BR-3 breast cancer cells in cell culture studies.
50
  With the use of PEG-coated 
gold nanorods injected at tumor sites of mice, Bhatia et al. were able to use X-ray 
computed tomography as a guide for photothermal therapy with high efficacy due to the 
optical properties of gold nanoparticles.
51
   
 Drug Delivery is another promising application of Au NPs.  Drug loading onto Au 
NPs can be done with high efficiency due to the high surface area of the particles.  Drug- 
loaded Au NPs show enhanced pharmacokinetics and tissue accumulation compared to 
free drugs.
52
 Due to the leaky vasculature of tumor cells, the enhanced permeability and 
retention (EPR) effect leads to the preferential accumulation of the NPs at the tumor 
sites.
53
  Au NPs are a useful tool for the delivery of the drugs to cellular destinations due 
to their ease of synthesis, functionalization and biocompatibility. Another advantage of 
12 
 
using Au NPs for drug delivery is their capability for bioimaging due to their strong 
optical properties.  Recently, paclitaxel, (PTX), an anticancer drug, was loaded onto gold 
nanorods with a high density (2 x 10
4
 PTX/Au NR) via a facile, fast, and highly efficient 
method.  The drug was efficiently released to exert cytotoxic effects via hydrophobic 
interactions of the drug and apolar lipid membrane.
28
  Multimodal delivery systems can 
also be used, where Au NPs are loaded with several drugs (hydrophilic and hydrophobic) 
as well as target molecules to ensure better delivery to the target cell and also help anchor 
the drugs.
20
 Au NPs are also excellent delivery vectors for substances such as antibiotics 
and other antibacterial agents.  Gu et al. have prepared a stable vancomycin–colloidal 
gold complex and showed its effectiveness toward various (including vancomycin-
resistant) enteropathogenic strains of Escherichia coli, Enterococcus faecium, and 
Enterococcus faecalis.
54
   
 Au NPs offer many applications in biomedicine due to their unique chemical 
properties such as excellent ability to absorb and scatter light, ability to transfer light 
energy as heat, facile surface modification, and biocompatibility. Although Au NPs have 
these unique properties described above, they still have limitations. Au NPs cannot be 
used for magnetic separation due to the their lack of magnetic properties. Likewise, they 
lack capabilities for MR imaging. Thus, it will be desirable to develop hybrid NPs that 
possess both magnetic and optical properties.    
1.4. Iron oxide-gold core-shell nanoparticles 
 Although magnetic and plasmonic nanoparticles are two of the most widely used 
nanoplatforms in biomedicine, each type of nanoparticle displays distinct limitations.   
Combining these two platforms into a single hybrid nanoconstruct would create a highly 
13 
 
attractive multi-modal system for biomedical applications. Due to the biocompatibility 
and the excellent properties of IO and Au NPs, iron oxide core-gold shell (IO-Au) NPs 
have attracted considerable interests. They are promising for a broad range of single and 
multi-modal applications including MRI, optical imaging, cell separation, biosensing and 
photothermal therapy.   
 Recently Zhou et al. used IO-Au NPs to isolate and detect proteins.
55
  They 
coated the NPs with Raman reporters and conjugated them with antibodies specific to 
protein specific antigen (PSA), one of the most widely used Food and Drug 
Administration-approved biomarkers for cancer detection.  They were able to isolate the 
PSA by magnetic separation and detect rapidly with SERS.  This was a simple, rapid 
determination which did not require any sample pretreatment.
55
 
 The synthesis of these hybrid IO-Au NPs has gained great attention. A variety of 
methods has been reported.
56
  However, most synthesis methods make IO-Au 
nanospheres. For examples, Li et al. synthesized IO-Au NPs by linking two separately 
prepared Fe3O4 and Au NPs through chemical bonds.  The Fe3O4 were conjugated with a 
thiol group. Then Au NPs were prepared separately by the reduction of a gold salt with 
sodium borohydride. The two types of NPs were mixed together to form IO core with 
gold seed spheres (Figure 1.3).
57
  This method does not make a uniform Au shell which 
limits its plasmonic effects and its facile surface modification and does not have NIR 










 Sun and co-workers successfully prepared core/shell Fe3O4/Au NPs based on the 
heterogeneous nucleation and growth of Au onto seeded NPs.
58
  They first reduced a gold 
salt (HAuCl4) solution on the surface of Fe3O4 NPs with a solution of olelyamine. They 
are then mixed with a stabilizing surfactant, cetyltrimethylammonium bromide (CTAB) 
and sodium citrate.  This method produces a smooth gold shell by simply adding more 
gold salt in a reducing condition.
58
 By increasing the thickness of the gold shell they 
showed a slight red shift in their maximum absorption from ~540-560 nm (Figure 1.4).  
One limitation to this method for biomedical purposes is they use a small iron oxide core 
(10 nm) which has limited magnetic properties. In addition, the nanospheres do not 






Figure 1.4. (A) Absorption spectra of IO-Au/Ag shell nanospheres synthesized via a 





 Lyon et al. prepared IO-Au core-shell NPs by sequential deposition of Au onto  
Fe3O4 NPs via an iterative hydroxylamine seeding method.
59
  The NPs absorb light 
around 525 - 570 nm depending on the shell thickness.  The particles generated by this 
method are also limited due to weak magnetic properties and no absorption in the NIR 
region.  The synthesis method is also tedious due to the multiple depositions of gold 
required to make a uniform shell. 
 NIR absorption is critical for in vivo imaging and therapy because of minimal 
light absorption by water and hemoglobin in this range and the resulting optimal light 
penetration in tissue.
60
 A few studies have demonstrated that NIR-absorbing magnetic–
optical NPs can be achieved by using large IO core and/or thick shell of Au, resulting in 
NPs with overall size of around or greater than 100 nm. For examples, Wang et al. 
developed a method in which magnetite NPs (~258 nm) were coated with a thin polymer 
16 
 
layer and then citrate stabilized gold nanoseeds were attached via electrostatic 
interactions (Figure 1.5).
61
  A uniform gold shell was then developed by reducing 
HAuCl4 onto the seeded NPs. Unlike the previous methods discussed above in which 
direct coating of magnetic NPs with gold shells did not produce NIR absorption, NIR 
absorption was achieved in this method with an total size of ~273 nm for the iron oxide-
gold core-shell NPs. 
 
 
Figure 1.5. (a)Absorption spectra of iron oxide cores with various gold shell thickness (b) 




 The authors speculated that the polymer gap, although very thin, helped maintain 
the NIR absorption of the gold nanoshell, possibly by interrupting the interactions 
between the gold shell and the magnetite core. However, the large size of core also 
contributes to the NIR absorption of the hybrid NPs as shown previously on silica-gold 
core-shell NPs.
62
  One potential limitation to the previous method is the large particle size 
(273 nm).  It is well know that for better tissue penetration and blood circulation, 
nanoparticles with a smaller size are desirable (< 100nm). 
17 
 
 Later, Wei et al. developed a method in which IO-Au core shell nanostars were 
synthesized.
63
 They firstly synthesized IO NPs (~8-13 nm).  The IO NPs were then 
treated with AuCl3
2-
 at room temperature followed by heating to 190 °C in octyl ether for 
90 min to form IO-Au core-shell NPs (~9-16 nm).  The NPs were then deposited into a 
micellar solution containing cetyltrimethylammonium bromide (CTAB), chloroauric acid 
(HAuCl4), silver nitrate (AgNO3) under reduced conditions to grow into nanostars (~150-
200 nm).  These particles exhibited absorption maxima around 800 nm, but their 
magnetic properties are very limited because of the small size of the IO core (8-13 nm) 
compared to the large overall size of the hybrid NPs. Jin et al. formulated NIR responsive 
IO–Au nanospheres (50 nm or less) with ultrathin Au shells by building a polymer gap 
between the IO core and the Au shell.
64
  The authors coated magnetite NPs (~25 nm) 
with a polymer layer (~3 nm) with a charged peptide, poly- L -histidine.  The peptide 
allowed Au
3+
 ions to chelate onto the surface of the IO NPs which was then reduced to 
Au
0
. The NPs with a very thin Au layer (1-3 nm) exhibit a broad NIR absorption.  As the 
shell thickness grows (4-5 nm), the core-shell NPs blue shifted to visible spectral region. 
This method is limited for biomedical applications due to the expensive chemcials of the 
synthesis (especially poly- L –histidine), making it a difficult method for large scale 
synthesis.   
1.5. Motivation 
 The development of nanomaterials that combine diagnostic and therapeutic 
functions within a single nanoplatform is extremely important for molecular medicine.  
IO and Au NPs are two of the most widely used nanoplatforms in biomedicine.  
Combining these two platforms into a single hybrid nanoconstruct would create a highly 
18 
 
attractive multi-modal system for biomedical applications. While the inner IO core could 
serve as potential agents for MRI and separation, the outer Au shell would be a useful 
tool for optical imaging, drug delivery, photothermal therapy, spectroscopic detection and 
molecular targeting. However, it is challenging to develop IO-Au core-shell NPs with 
optical properties in the NIR window while maintaining the superparamagnetic property 
of the IO core.  The importance of NIR absorption for photothermal therapy is essential 
due to the minimal light absorption by water and hemoglobin and the resulting optimal 
light penetration in tissue.
60
  Another key challenge is engineering IO-Au NPs for SERS 
applications without dampening the magnetic properties.   
 Here, we have developed IO-Au core-shell NPs with varying morphology and 
size with a single method.  The method is advantageous due to the simplicity and the 
feasibility of the synthesis of the core-shell NPs on a large scale. Our method also 
provides an inexpensive way to synthesize IO-Au core-shell NPs. The hybrid NPs can 
have an important impact on medical imaging, molecular diagnostics and cancer 
therapeutics. The synthesis, morphology, magnetic and optical properties of these core-




CHAPTER 2. EXPERIMENTAL METHODS 
2.1 Chemicals 
 All chemicals were purchased from Sigma-Aldrich and used as received unless 
specified.  QSY 21 carboxylic acid, succinimidyl ester (QSY 21) was purchased from 
Life Technologies (Grand Island, NY, USA).  Methoxy-PEG-thiol (mPEG-SH, MW 
5000) was purchased from Laysan Bio, Inc (Arab, AL, USA).  IO NPs (SHP 25) were 
obtained from Ocean Nanotech (Springdale, AR, USA) 
2.2 Synthesis of iron oxide-gold core-shell nanoparticles 
IO-Au core-shell NPs were synthesized via a seed-mediated growth method with 
modifications.
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  Firstly, IO NPs (SHP 25) were coated with small silver (Ag) NPs to 
form "seed" particles (Figure 2.1). This was done by reduction of Ag
+
-adsorbed IO NPs. 
Specifically, 1 mL of 10 mM diamminesilver ion complex (Ag(NH3)2
+
) was prepared by 
adding 20 uL of 1 M ammonia into 1 mL of 10 mM silver nitrate (AgNO3). After vortex 
mixing for 2 to 5 min, 10 µL of the Ag(NH3)2
+
 complex was added to a reaction vessel 
which contained 100 µL of 1 mg/mL negatively charged polymer-coated IO NPs and 
stirred for 30 min. The Ag
+
-adsorbed IO NPs were purified by centrifugation (10,000 
rpm, 8 min) and reconstituted with 0.25 mL of ultrapure water.  Sodium borohydride 
(NaBH4) (10 uL, 10 mm) was added to the reaction flask to reduce the Ag+ on the 
surface of the IO NPs to form Ag-coated IO NPs. The solution was stirred for 40 minutes 
to complete the reaction.  The Ag-decorated IO NPs were purified by three rounds of 
centrifugation and washing (10,000 rpm, 8 min), and were redispersed in 500 µL of 





Figure 2.1. Schematic illustration of Ag-decorated IO NPs. 
 
 The second step of the synthesis is the growth of Au shell on the Ag-decorated IO 
NPs (Figure 2.2). In a typical procedure, 54 mg CTAB was added to 1.5 mL of ultrapure 
water in a glass vial and then heated with stirring to dissolve. After allowing the solution 
to cool to room temperature, 60 uL of 10 mM HAuCl4 was added to the reaction mixture 
and the solution turned orange.  The solution was allowed to stir for 10 minutes.  To 
make spherical IO-Au NPs, 23 µL of 40 mM L-ascorbic acid (AA) was quickly added to 
reduce the HAuCl4 to HAuCl2. The reduction reaction changed the solution from orange 
to colorless.  The solution was then placed in a 25
o
C water bath and allowed to stir for 5 
minutes.  Next, a specified amount of Ag-decorated IO NP solution was rapidly injected 
and the solution was stirred for 10 seconds.  The mixture was then left still for the growth 
of Au shell onto IO NPs. By varying the amount of the IO-Ag seed, the overall size of the 
IO-Au NPs can be easily tuned.  After a few minutes, the solution changed to a pinkcolor, 
indicating the growth of iron oxide-gold nanospheres (IO-Au NSs). The growth process 





Figure 2.2. Schematic illustration of a typical procedure for the growth of Au shell onto 
Ag-decorated IO NPs to form IO-Au core-shell NPs. The formation of spheres, ovals or 
pins depending on the concentration of AgNO3 and AA.  
 
   For the preparation of IO-Au NPs nanoovals (IO-Au NOVs), 120 uL of 1 mM 
AgNO3 was added after the addition of HAuCl4 solution.  The solution was allowed to 
stir for 10 minutes.  Then, 23 µL of 40 mM AA was added to reduce the HAuCl4 to 
HAuCl2 with the solution changing from orange-gold to colorless.  The solution was then 
placed in a 25
o
C water bath and allowed to stir for 5 minutes.  Next, the Ag-decorated IO 
NP solution was injected rapidly and the solution was allowed to stir for 10 seconds.  
Then, the solution was left unstirred for an additional 2 h.  After a few minutes, the 
solution slowly began changing to purple, indicating the growth of IO-Au NOVs. By 
varying the amount of the IO-Ag seed, the overall size of the IO-Au NPs can be facilely 
tuned. 
 For the preparation of IO-Au nanopins (IO-Au NPINs), the same amount of 
AgNO3 was added as the preparation of NOVs.  Then, 150 µL of 40 mM AA was added 
to reduce the HAuCl4 to HAuCl2 with the solution changing from orange-gold to 
colorless very rapidly.  The solution was placed in a 25
o
C water bath and allowed to stir 
for 5 minutes.  The Ag-decorated IO NP solution was injected rapidly and the solution 
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was allowed to stir rapidly for 10 seconds.  After the 10 second stirring, the growth 
solution was left unstirred. By varying the amount of the IO-Ag seed, the overall size of 
the IO-Au NPs can be facilely tuned.  After a few minutes, the solution started to change 
color to blue, indicating the growth of IO-Au NPs in pin shapes. All IO-Au NPs are 
washed 3 times (10,000 rpm/10min) to remove excess CTAB in order for further 
characterization. 
2.3 Characterization of iron oxide-gold nanoparticles 
 The IO-Au NPs in different shapes were characterized by spectroscopic and 
imaging methods in order to measure the optical absorption properties, size and shape, 
and magnetic properties. The absorption spectra were measured using a VIS-NIR 
absorption spectrometer (Ocean Optics, Dunedin, FL).  To measure magnetic properties, 
IO-Au NPs were made in bulk (200 mL scale).  The particles were then purified and 
condensed to 5 mL and placed on a watch glass.  The solvent was then evaporated with 
N2 gas and the NPs were placed in on oven to dry.  After overnight drying the particles 
were in powder form and the magnetic properties were measured using a vibration 
sample magnetometer (Dexing Magnets, China). The magnetic properties of IO NPs were 
also measured for a comparison.  To further examine the magnetic properties of the NPs, 
a solution of the NPs in water was placed against external magnets (12-tube magnet, 
Qiagen). After a few hours, the magnetic NPs were separated from the solution and 
attached to the vial wall against to the magnet. To examine the size and morphology of 
the NPs, 10 uL of 0.1 nM NP solution was placed onto a 200 mesh copper grid with a 
formvar/carbon support film and let dry for 4 h. The samples were then examined using 
JEM1200EX II Transmission electron microscope (TEM) (JEOL Ltd, Tokyo, Japan).  To 
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further examine the size of the NPs, dynamic light scattering (DLS) was used to measure 
the hydrodynamic size of the IO and IO-Au NPs on a Malvern Zetasizer Nano ZS90 at 
room temperature (Brookhaven Instruments Corp, NY, USA).   
2.4 Surface enhanced Raman scattering measurement 
 The IO-Au SERS NPs (nanospheres, nanoovals, nanopins) were prepared by 
direct adsorption of QSY21, followed by stabilization with methoxy-poly (ethylene) 
glycol (mPEG-SH).  First, 50 µL, 0.1mM QSY21 was added to 1 mL of 0.1 nM IO-Au 
NPs.  The mixture was vortexed in the dark for 15 min to allow the adsorption of the dye 
onto the NPs.  This was followed by the addition of 50 µL, 0.1 mM mPEG-SH to saturate 
and stabilize the surface of the NPs.  The mixture was vortexed for 2 h in the dark at 
room temperature. The resulting mPEG/QSY/IO-Au NPs were centrifuged and washed 3 
times (10,000 rpm, 10 min) to separate unbound molecules. The NPs were redispersed in 
1 mL ultrapure water.  The molar ratios of QSY and mPEG-SH to IO-Au NPs were 
5x10
4
:1, which were calculated based on their volume and molar concentrations. The 
molar concentration of the IO-Au NPs are calculated based off of the stock IO NP 
concentration, 0.29 µM. The working IO-Ag
+
 seed solution concentration is 0.01 µM. 
The concentration of IO-Au NPs can then be controlled by the amount of seed injected 
into the 1.5 mL growth solution.  For a 22 µL sample, the concentration of IO-Au NPs is 
~0.1 nM.  This concentration accounts for a 10 percent loss after many purification steps.       
The SERS signals were collected from 0.1 nM IO-Au SERS NPs on a ProRaman-L 
porter Raman spectrometer (Enwave Optronics, Irvine, CA). The focus of the laser was 
adjusted to obtain maximum signal.  The signals were detected with a CCD camera cool 
to -60
o
C. The excitation wavelength was 785 nm and the power was 10 mW with an 
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acquisition time of 0.1 s.  A baseline correction using multi-segment polynomial fitting 
(Provided by Enwave) was utilized to subtract the background. 
2.5 Photothermal experiment 
 To examine the photothermal effect of the nanoparticles, 808 nm CW NIR light 
from a portable diode laser (Power technologies, Little Rock, AR) was delivered to the 
NP solution (100 µL) at the specified concentration in a 1.7 mL microcentrifuge tube. 
The particles were irradiated for up to 8 minutes.  The laser beam was 1 cm in diameter 
and the power density was 0.55 W/cm
2
. A thermocouple was inserted into the solution 




CHAPTER 3. RESULTS AND DISCUSSION 
3.1 Synthesis and characterization of iron oxide-Ag Seed  
 We used SHP 25 IO NPs to make IO-Au NPs in different shapes. The NPs are 
spherical and averagely 23 nm in diameter and are highly monodisperse. (from 100 NPs) 
(Figure 3.1). The NPs do not show any strong absorption peaks above 400 nm. (Figure 
3.2). The NPs consist of a monolayer of oleic acid and a monolayer of amphiphilic 
polymer (poly(maleic anhydride-alt-1-octadecene) that interacts with oleic acid with their 
hydrophobic alkyl chain while exposing the hydrophilic carboxylate ions to anchor 
positively charged metal ions. The reactive carboxylate groups also make the NPs water 






3.1. (a) TEM image IO NPs. (b) size distribution of IO NPs.  
 
The magnetic properties of the IO NPs were tested by placing them against an 
external magnet (surface field: 5000 Gauss, Figure 3.3(a)). The solution of NPs appeared 
brown before magnetic separation. After separation, the particles were attracted to the 
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magnet and separated from the aqueous solution  The particles are completely attracted to 
the magnet within a few hours. The magnetic properties were also quantitatively 
examined with a magnetometer at room temperature.  Figure 3.3(b) shows the M-H curve 
of the iron oxide particles.  The NPs are superparamagnetic which is crucial for 
biomedical applications to avoid magnetization residue-induced aggregation. The NPs 
display a strong magnetization, with a saturation magnetization of ~50 emu/g. 
 
 






Figure 3.3. (a) Magnetic separation of IO NPs in the presence of an external magnetic 
field. (b) M-H curve of IO NPs at room temperature.  The nanoparticles display a 
superparamagnetic curve. 


























 The amphiphilic polymer layer with carboxyl groups on the surface allowed for 
silver ammonia complex ions (Ag(NH3)
2+
) to adsorb onto the surface of the IO NPs.  
Ag(NH3)
2+ 
is known to be adsorbed onto negatively-charged NPs with high density by 
electrostatic interactions.
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  This enables facile formation of small Ag NPs (~2 nm) on the 
surface of the IO NPs by reduction with sodium borohydride (Figure 3.4). The small Ag 
NPs on the surface of the IO NPs were used as the catalyst for Au shell growth. Without 
the Ag NPs on the IO NPs, IO-Au core-shell NPs were not formed, leading us to believe 
the fine Ag NPs on the surface of the IO served as nucleation sites. 
 
 
3.4. TEM image of IO NPs (~20 nm) with 2-3 nm Ag NPs attached to the surface used as 
the catalyst for the formation of the Au shell onto the IO NPs.   
 
 
3.2 Synthesis and characterization of IO-Au nanospheres 
 The geometry of IO-Au NPs was controlled by the concentration of AgNO3 and 
AA in the growth solution. To make spherical IO-Au NPs, there was no AgNO3 in the 
growth solution. The concentration of AA was 61 uM.  The growth solutions (1.5 mL) 
were kept at 25
o
C in a water bath.  This was crucial due to the fact that the CTAB will 
precipitate out of solution below 23
o
C leading to polydispersed nanoparticle formation. 
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Within a minute of the IO-Ag seed particle being injected into the spherical growth 
solution a pink color started to appear.  The final color of the spherical NPs appeared to 
be a pink to red color.  This is similar to the color of solid Au nanospheres (NSs).  The 
surface catalyzed reduction of HAuCl2 led to the formation of uniform Au shells on the 
IO NPs. After purification by centrifugation (10,000 rpm, 8 min, 23
o
C), the hybrid NPs 
were stable at room temperature for months.  By adding different amounts of seed NPs, 
IO-Au nanospheres with different sizes were prepared. Figure 3.5 shows the absorption 
spectra of various sizes of IO-Au NSs by adding different amounts of IO-Ag seeds from 
2 to 26 uL (~0.1 nM). IO NPs do not absorb light in the VIS-NIR region (Figure 3.2). 
However, IO-Au core-shell NSs exhibited strong surface Plasmon resonance (SPR) 
absorption in this region (Figure 3.5). The more seed that was added, the smaller IO-Au 
NSs were formed due to limited amount of gold solution. As the size of the NPs 
increased, the SPR slightly red shifts.  This is similar to Au NSs, which also exhibit a 
similar red shift with an increase in size.
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  Further increasing of the sizes lead to 





Figure 3.5.  The absorption spectra of IO-Au nanospheres with varying amount of IO-Ag 
seed. As the particle size increases (decreased amount of seed), the surface Plasmon 
resonance absorption slightly red shifts from 530-560 nm. 
 
The size and morphology of the NPs were characterized via TEM (Figure 3.6). It can be 
seen that uniform IO-Au NPs were formed.  The IO-Au NSs appear darker than the IO 
NPs (Figure 3.1(a)).  This is expected as Au has a much higher density compared to Fe.  
It is well known that elements with higher densities have better contrast in TEM.
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  The 
sizes of IO-Au NSs were tuned by varying the amount of IO-Ag seed. When 26 µL IO-













































Figure 3.6. (a) TEM image of ~40-50 nm IO-Au nanospheres (26 µL seed).  The Au shell 
grows uniformly onto the IO-Ag seeded particle. (b)  TEM image of ~50-60 nm IO-Au 
nanospheres (22 µL seed). (c) TEM image of ~70-80 nm IO-Au nanospheres (14 µL 
seed) and (d) TEM image of ~100-110 nm IO-Au nanospheres (2 µL seed) 
 
 The size of the IO-Au NPs (26 uL) was about 40 to 50 nm. As the IO core is 
about 25 nm, the shell of Au is 7 – 13 nm. When the amount of seed NPs was reduced to 
22 uL, free IO NPs were barely observed (Figure 3.6(b)). The size of the hybrid NPs 
increased to 50 to 60 nm. When the amount of seed NPs was further reduced to 2 uL, the 
size of the IO-Au NPs increased to above 100 nm, with the Au shell of over 35 nm in 
thickness. 
TEM can determine the size and examine the shape of the NPs. However, they 
cannot obtain information on the surface charge. In addition, the surface capping 
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materials (CTAB in our studies) might also contribute the size of the NPs. Thus, we 
further examined the hydrodynamic diameter (HD) of the IO-Au NPs in aqueous 
solution. Table 3.1 shows a summary of the HD and zeta potential () of IO-Au NPs 
made from different amount of seed.  By decreasing the amount of IO-Ag seed injected 
into the growth solution, the IO-Au NPs size increases.  The HD is slightly larger than the 
size measured by TEM due to the CTAB bound to the IO-Au NPs and outer hydration 
layer.  The CTAB attached to the surface of the NPs caused the NPs to have a positive 
surface charge as shown by the zeta potential  in Table 3.1.  
 
Table 3.1. Hydrodynamic diameter (HD) and Zeta Potential () of IO-Au   
 nanospheres prepared from different amount of seed.   
 






68.0  2.2 
75.7 2.0 
28.5  0.5 
29.4  0.7 
18  84.1  1.1 30.8  0.8 
14  95.3   2.6  30.5  0.5 
10  105.0  4.1 29.9  0.6 
6  
2 
109.8  6.5 
116.5  3.5 
30.5  0.7 
31.3  0.7 
 
 
 Next the magnetic properties of the IO-Au NSs were tested by placing the NP 
solution against an external permanent magnet (surface field: 5000 Gauss).  Figure 3.7 
shows the pictures of the NP solution before and after separation of the NPs from 2 - 26 
uL samples.  The 26, 22, 18, and 14 uL IO-Au NPs were attracted to the magnet after 2 h, 
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leaving a clear solution. This indicates the good magnetic properties of the NPs. This 
further confirmed that the NPs are indeed core-shell NPs, not solid Au NPs. When the 
size of the NPs increased, the magnetic properties decreased and the NPs could not be 
completely separated from solution.  In fact, for the 2 uL sample there was no magnetic 
separation.  This is because of the increased content of diamagnetic Au for larger NPs.      
 
 
Figure 3.7. Magnetic separation of IO-Au NSs prepared from different amounts of seed 
from 26 uL -2 uL (left to right). The top is an image of the NPs before exposure to the 
magnet.  The bottom image is taken after 2 hours. The 26-14 uL seed samples show 
excellent magnetic separation with all of the NPs attracted to the magnet. In the 10 uL 
sample most NPs are attracted to the magnet, but there are some NPs that sediment down 
to the bottom of the tube.  6 and 2 uL samples are too large to be magnetically separated. 
 
3.3 Synthesis and characterization of IO-Au nanoovals 
 Compared to spherical NPs, anisotropic NPs gave better or new properties due to 
curvature effects.
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 Thus, we tried to make anisotropic IO-Au NPs, which would have 
promising biomedical applications. Fortunately, we found we could make anisotropic IO-
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Au core-shell NPs using the same method to the preparation of IO-Au nanospheres with 
modifications. In addition, we could make different shapes of IO-Au NPs by controlling 
the synthetic parameters. Using these altered conditions we made IO-Au NPs in oval and 
pin shapes.  
The IO-Au nanoovals (NOVs) were made from the same procedure to that of the 
IO-Au NSs described above except that the growth solution contained AgNO3. Ag+ has 
been shown to make anisotropic NPs by selectively binding to the (111) facet of gold 
surface.
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 The effect of AgNO3 in the growth process of the IO-Au core-shell NPs was 
first tested by varying the amounts of AgNO3 in the growth solution. Figure 3.8 shows 
TEM images of IO-Au NPs at different concentrations of AgNO3.  The seed amount in 
this experiment is 22 uL. When the concentration of AgNO3 was 40 uM, the particles 
start to become anisotropic (Figure 3.8(b)) compared the IO-Au nanospheres without the 
presence of AgNO3. When the concentration of AgNO3 was increased to 80 uM, the 
particles then became more anisotropic and NPs appeared in oval shapes (Figure 3.8(c)).  
After tripling the concentration of AgNO3 (120 uM), the particles became polydisperse 
including appearance of some spherical NPs. Thus, IO-Au NOVs were made at an 
















      
Figure 3.8.  TEM images of IO-Au NPs with varying silver ion concentration in the 
growth solution. (a)  No silver ions, (b) 40 uM AgNO3, (c) 80 um AgNO3 and (d) 120 uM 
AgNO3. 
 
 After we obtained the optimal concentration of AgNO3 for making IO-Au NOVs, 
we made IO-Au NOVs of different sizes (or different Au shell thickness) by using 
different amounts of seed. By lowering the amount of seed, IO-Au NPs with larger sizes 
were formed. Figure 3.9 shows that IO-Au NOVs exhibit SPR from 565 to 620 nm 
depending on the amount of injected seeds. As the amount of seed decreased, the SPR 
wavelength red shifted. Compared to the IO-Au nanospheres, which had SPR of 530-550 
nm (Figure 3.5), the SPR of NOVs was slighted red shifted.  It was also noted that the 
absorption spectrum became broader with a decrease in the amount of seed NPs. This is 





Figure 3.9. Absorption spectra of IO-Au NOVs with varying amount of IO-Ag seeds.  
The particles showed a SPR from 565 - 620 nm depending on the amount of seeds 
 
 Figure 3.10 shows TEM images of IO-Au NOVs prepared from different amounts 
of seeds. When 22 uL IO-Ag seeds were used, the resulting IO-Au NPs were oval in 
shape, with an average size (100 particles) of 60 nm along the long axis and 50 nm in 
short axis (Figure 3.10 (a)). The shell of Au was estimated to be 12 to 18 nm in thickness 
considering an IO core of 25 nm.  When the size of the NPs increased, the oval shape 
remained.  The thickness of the Au shell increased proportionally in the oval shape.  At 
very low amounts of IO-Ag seed (2 - 6 uL), the NPs ranged from 80 to 120 nm in overall 
size.  These results showed that the size of the NPs could be tuned by controlling the 









































Figure 3.10. (a) TEM image of the IO-Au NOVs (22 uL seed). The particles are ~60 nm 
along the long axis and ~50 nm in short axis. (b) TEM image of IO-Au NOVs (18 uL 
seed). The NPs are ~70 nm along the long axis and 60 nm along the short axis. (c) TEM 
image of IO-Au NOVs (10 uL seed). The NPs are ~90 nm along the long axis and 80 nm 
along the short axis. (d) TEM image of IO-Au NOVs (6 uL seed). The NPs are ~90 nm 
along the long axis and 120 nm along the short axis. 
 
 Similar to IO-Au NSs, the HD and  of the IO-Au NOVs were examined using 
DLS.  Table 3.2 shows the average HD and  of the IO-Au NOVs at different IO-Ag seed 
injections. When the amount of seed was decreased, the sizes of the IO-Au NOVs 





Table 3.2. Hydrodynamic diameter (HD) and Zeta potential () of IO-Au NOVs at 
various amounts of the seeds.  The surface of the NPs are positively charged due to the 
CTAB surfactant. 
 






72.3  1.3 
78.4 1.8 
29.5  0.6 
29.4  0.8 
18  86.4  0.8 28.8  0.8 
14  94.5   0.6  29.5  0.5 
10  98.7  3.1 30.0  0.9 
6  
2 
103.8  2.7 
114.5  3.2 
30.7  0.5 
30.5  0.4 
    
 The magnetic properties of the IO-Au NOVs were tested by both qualitatively via 
magnetic separation and quantitatively via a vibration magnetometer. We selected the 
NOVs of 50 to 60 nm (seed 22 uL) for the measurement. Similar to IO-Au nanospheres, 
the NOVs at these sizes showed strong magnetic properties. After the NOV solution was 
attached to the magnet, the NPs were separated from the solution and attached to the wall 
of the vial on the side of the magnet (Figure 3.11(a)). It took around 2 h for a complete 
separation. This confirmed that the IO-Au NOVs maintained the magnetic properties of 
the IO core.   
For magnetic-related biomedical applications, the NPs have to be 
superparamagnetic to avoid magnetization residue-induced aggregation. It is known that 
the magnetic property of IO NPs is size dependent. The critical size for the 
superparamagnetic property of IO NPs is < 30 nm, with larger size bearing ferromagnetic 
properties. The IO NPs we used were 25 nm in diameter. We expect that the IO-Au 
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NOVs would be superparamagtic, too. To further confirm whether the hybrid NOVs were 
superparamagnetic, the magnetic properties were quantitatively examined using a 
vibration magnetometer at room temperature. Figure 3. 11(b) shows the plot of the 
magnetization of the NPs versus the applied external field (M-H curve). Similar to the IO 
NPs, the NPs are superparamagnetic. The NOVs were magnetized under external 
magnetic field. When the magnetic field was removed, the magnetization went back to 
zero. However, the saturation magnetization of the NOVs were about 6 times lower than 
that of pure IO NPs. (Figure 3.11 (b)). This is not surprising because of the mass 
contribution from the diamagnetic Au that has 4 times larger density than IO.  The CTAB 
surfactant also contributed to the mass of the materials during the measurements.    
 
(a)       (b) 
 
Figure 3.11. (a) Magnetic separation of IO-Au NOVs (50-60 nm) under external 
magnetic field.  The nanoparticle solution appeared purple before separation. The 
solution becomes clear after the NPs were attracted to the magnet indicating the IO-Au 
NOVs preserve the magnetic property of the IO core. (b) M-H curve for IO-Au NOVs 
(50-60 nm). The NPs maintained the superparamagnetic properties of the IO core.  The 
NOVs have a saturation magnetization of ~8 emu/g.  
 


























To examine the effect of the magnetic properties of the NOVs by the particle size, 
we invested the magnetic separation of IO-Au NOVs of different size. Figure 3.12 
showed the magnetic separation of IO-Au NOVs made from different amount of seeds (2 
– 26 uL). Simialr to the spheres, increasing the size of the NPs lead to decreased 
magnetic properties of the hybrid NPs. This is not surprising due to the increased 
concentration of dimagnetic gold for larger NPs. For the hybrid NPs made from 2 uL 




Figure 3.12. Magnetic separation of IO-Au NOVs prepared from different amount of seed 
from 26 uL -2 uL (left to right). The top is an image of the NPs before exposure to the 
magnet.  The bottom image is taken after 2 hours. The 26-14 uL seed samples show the 
NPs attracted to the magnet indicating they are indeed core-shell NPs. In the 10 uL 
sample most NPs are attracted to the magnet, but there are some NPs that sediment down 
to the bottom of the tube.  6 and 2 uL samples are not magnetically separated and show 








3.4 Synthesis and characterization of IO-Au nanopins 
 During the growth of the gold shell, HAuCl2 was reduced by AA to Au
0
 that were 
deposited onto the IO surface to form IO-Au core-shell NPs. The speed of deposition of 
the Au atoms would greatly affect the shape of the hybrid NPs. Thus, we first examined 
the role of AA on the shape of the IO-Au core-shell NPs using 18 uL seeds. The presence 
of 1.6 mM AA in the growth solution containing 80 uM AgNO3 led to IO-Au NPs with 
longer tips (Figure 3.14 (a)).  The concentration of the AA is about 3 times higher than 
that used for making NOVs. By further increasing the concentration of AA to 4 mM, 
more NPs with pin like shapes were found (Figure 3.14 (b)). Further increasing AA to 8 
mM did not increase the population of pin-shaped NPs, but increased the population of 




















































Figure 3.13. TEM image of IO-Au NPs prepared with (a) 1.6 mM AA, (b) 4 mM AA and 
(c) 8 mM AA. AA with concentration equal or higher than 4 mM led to the formation of 
pin-shaped IO-Au NPs. (d) Absorption spectra of IO-Au NPs prepared with 1.6 mM, 4.0 
mM and 8.0 mM AA. 18 uL seeds were used in these samples. 
 
The absorption spectra of these NPs are shown in Figure 3.13 (d). It shows that 
the IO-Au NPs have two peaks, one strong peak at 600 nm and the other one in the longer 
wavelength (Figure 3.13(d)). The 600 nm absorbance is most likely due to the presence 
of IO-Au NSs and NOVs. The peak at longer wavelength is due to the presence of 
NPINs. With the increase of AA, the intensity of the second peak increased. At 1.6 mM 
AA, there was small peak at 775 nm. Increasing the concentration of AA to 4. 0mM led 
to a strong peak at 850 nm. When the concentration of AA was further increased to 8 
mM, the wavelength of this peak was blue shifted to 790 nm with a decrease in intensity. 
This is consistent with the results from TEM. AA stimulated the formation of pin-shaped 
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NPs. However, too much AA would lead to destruction of the pin tips and thus giving 
more spherical NPs.     
We then made IO-Au NPINs with different sizes using different amount of seeds. 
The amount of seeds used was 26, 22, 18 and 10 uL. The concentration of AA was 4 mM 
and that of AgNO3 was 80 uM.  Figure 3.14 showed the absorption spectra of these NPs. 
As the amount of seeds increased, the peak for the NPINs in the NIR region was red 
shifted. When 26 uL seeds were used, the NPINs showed a SPR at 774 nm. When 10 uL 
seeds were used, the NPINs showed a SPR at 863 nm. This red shift was due to the 
increase of the size of the NPs, which was confirmed by TEM examination discussed 
below.  






























Figure 3.14. Absorption spectra of IO-Au NPINs prepared from different amount of 
seeds.  (A) 26 µL, (b) 22 µL,  (c) 18 µL seed and (d) 10 µL seed.   
 
Figure 3.15 shows the TEM images of IO-Au NPINs prepared from different 
amount of seeds. When 26 µL IO-Ag seed was used, the NPINs are 40-50 nm from the 
tip to base and 25-35 nm along the base. When 22 µL IO-Ag seed was used, the IO-Au 
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NPINs were typically 50-60 nm from the tip to base and 35-45 nm along the base (Figure 
3.16). When the amount of the seeds was decreased to 18 uL, NPINs are 60-70 nm from 
the tip to base and 40-50 nm along the base. When the amount of the seeds was further 
decreased to 10 uL, the NPINs are 90-100 nm from the tip to base and 50-60 nm along 
the base. In addition, the NPINs started to become polydispered and nanostars started to 











Figure 3.15. TEM images of IO-Au NPINs prepared from (a) 26 uL seeds, (b) 22 uL 
seed, (c) 18 uL seeds and (d) 10 uL seeds. In (a), the NPINs are 40-50 nm from the tip to 
base and 25-35 nm along the base. In (b), the NPINs are 50-60 nm from the tip to base 
and 35-45 nm along the base. In (c), the NPINs are 60-70 from the tip to base and 40-50 
nm along the base, and in (d), the NPINs are 90-100 nm from the tip to base and 50-60 






Figure 3.16. TEM image of a IO-Au NPIN from 22 µL IO-Ag seed sample. The IO-Au 
NPINs is 50 nm from the tip to base and 38 nm along the base. 
 
To further examine the size tuning by varying the amount of seeds, we 
characterized the NPs with DLS. Table 3.3 shows the average HD and  of the IO-Au 
NPINs. As the IO-Ag seed amount was decreased, the overall size of the NPs increased. 
Again, like the IO-Au NSs and NOVs, the NPINs were positively charged due the 
charged CTAB capping materials.    
 
Table 3.3. Hydrodynamic diameter (HD) and Zeta potential () of IO-Au NPINs at 
various amounts of seeds.  The NPINs have a positive surface charge. 
 






65.3  2.4 
68.0  1.9 
28.5  0.7 
28.4  0.6 
18  78.2  1.7 29.7  0.4 
14  82.1   2.6  29.8  1.1 
10  92.2  4.2 29.8  0.5 
6  
2 
103.7  3.5 
108.5  5.2 
30.1  0.9 





From the above studies, we can see that it was difficult to make high quality IO-
Au NPINs. At all conditions, IO-Au NSs contamination exists. Thus, to obtain pure IO-
Au NPINs, the sample was further processed by centrifugation at a specific speed and 
time so that significant amount of NSs were able to be separated. We conducted a 
systematic study, in which the as-prepared IO-Au NPINs were processed at different 
centrifugation time and speed. The as-prepared NP solution (1.5 mL) was centrifuged at a 
specified speed and time. After centrifugation, the supernatant and the pellet were quickly 
separated. Then, a thin blue film was found on the inner wall of the centrifugation vial. 
The film was rinsed off by water and collected for absorption measurement. Figure 3.17 
showed the absorption spectra of the sample collected from the inner wall of the 
centrifugation vial after centrifuged at different conditions. It is very clear that 
centrifugation led to the separation of IO-Au NSs and thus the increase of the population 
of IO-Au NPINs (increased intensity of the absorption peak in the NIR region). Lower 
speed favours the separation of NSs. As the speed was decreased, the centrifugation time 
was correspondingly increased. The IO-Au NPINs obtained from the separation of as-
prepared solution at 2000 rpm, 45 min showed an dominate peak around 810 nm from 

































Figure 3.17. Absorption spectra of IO-Au NPINs (22 uL seed) after separation of IO-Au 
nanospheres by centrifugation at different speed and different time. The as-prepared 
solution showed a major peak at 570 nm from IO-Au NSs and a second peak at 770 nm 
from IO-Au NPINs. When the solution was centrifuged at 5500 rpm for 20 min, the 
percentage of NPINs increased leading to the increase of the SPR bands at 780 nm. When 
the solution was centrifuged at 2000 rpm for 45 min, the intensity of the SPR band at the 
longer wavelength is stronger than the NSs, due to the separation of majority of NSs.   
 
 We further estimated the extinction coefficient of the IO-Au NPINs based on the 
injected amount of seeds and the relative ratio of IO-Au NPINs and NSs based on TEM. 






 at 800 nm. 
This is about an order of magnitude higher than gold nanorods.  Such a high absorption 
efficiency may benefit many applications including photothermal therapy.  
 The magnetic properties of IO–Au NPINs were confirmed by their separation 
under external magnetic field. We selected the NPINs made from 22 uL seeds for this 
study. This is because the NPINs of this size (50-60 nm in the longitudinal axis and 35-45 
nm in the transverse axis) had the SPR around 800 nm, a wavelength that overlapped 
very well with the laser wavelength used in photothermal therapy ( = 808 nm). When an 
external permanent magnet was placed close to the IO-Au NPIN solution, the NPs were 
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attracted to the magnet, indicating the strong magnetic properties (Figure 3.18 (a)).  The 
remaining liquid became colorless, indicating that the NPs were indeed core-shell NPs 
and preserved the magnetic properties of the IO core. The magnetic properties were 
quantitatively examined using a vibration magnetometer at room temperature (Figure 
3.18 (b)).  The saturation magnetization of the NPINs was about 6 emu/g. Compared to 
the pure IO NPs (Figure 3.3(b)), the gold coating reduced the magnetization about 8 
times. Similar to the IO-Au NOVs, the reduced magnetization is due to the larger density 
of the diamagnetic gold shell compared to the IO core.  The mass of the CTAB also 
slightly contributes to the loss of magnetization.      
In summary, we made a new generation of compact, uniform and NIR-absorbing 
magnetic-optical NPs. With the presence of 80 uM silver nitrate and 4 mM AA, IO-Au 
NPINs were formed.  The NPINs with absorption maxima around 800 nm has an average 
size (100 particles) about 50 nm from the tip to the base and 35 nm along the base.  Most 
importantly, we found that the hybrid nanopins exhibit extraordinary optical properties 











                              (a)                                                                            (b) 
 
Figure 3.18. (a) Magnetic separation of IO-Au NPINs placed against an external magnet.  
The nanoparticle solution appeared blue before separation. The solution became clear 
after the NPs were attracted to the magnet indicating that the IO-Au NPINs preserved the 
magnetic property of the IO core. (b) M-H curve for IO-Au NPINs. The NPs maintain the 
superparamagnetic properties of the IO core.  The NPINs have a saturation magnetization of ~ 6 
emu/g. 
 
3.5 Surface enhanced Raman scattering activities of iron oxide-gold nanoparticles  
 Surface enhanced Raman scattering (SERS) is one of the most powerful tools for 
biophysical and biomedical detections. As the enhancement can be as large as 10 
14-15
, it 
enables detection at single molecule/particle level.
71
  A key challenge in engineering IO-
Au NPs for SERS applications is to optimize size and geometry without dampening the 
magnetic properties. This is because SERS signals increase as the shell thickness 
increases.
72
  However, increasing the Au shell results in the decrease of the relative 
contribution from the magnetic IO in the hybrid NPs because Au is diamagnetic.  
Anisotropic NPs are known to give much stronger electronic field enhancement than 
isotropic spheres, a phenomenon that directly leads to increased Raman enhancement.
73
  
Here, we study the adsorption of a Raman tag, QSY 21, to the different IO-Au core-shell 
NPs synthesized hoping to achieve strong SERS activity from the anisotropic core-shell 






























NPs.  The Au shell on the IO NPs makes this a very facile process.  We chose the same 
overall particle size of 50-60 nm for the IO-Au spheres, ovals, and pins because at this 
size the core-shell NPs still posses excellent magnetic separation as well as strong optical 
properties.  This size is also an optimum size for biomedical applications.   
The SERS NPs were prepared by nonspecific adsorption of QSY 21, followed by 
covalent stabilization with mPEG-SH 5000 (Figure 3.19 using NOVs as an example). 
The mPEG-SH binding sites did not compete with the sites on the NPs for QSY 21. Thus, 
QSY 21-adsorbed IO-Au NPs were stabilized by hydrophilic PEG. We chose QSY 21 
(see Figure 3.20 for the structure) as the Raman tag because of its highly delocalized pi 
electrons that usually lead to strong Raman signals
74
. In addition, they are nonfluorescent 
and thus do not produce a background that could lead to interference of the Raman 












































Figure 3.19. Schematic illustration of the preparation of IO-Au SERS NOVs. 
 
 
Figure 3.20. Structure of QSY 21. 
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First, the maximum loading efficiency of QSY was determined by adding various 
amounts of QSY to the IO-Au NPs.  Ratios of IO-Au NPs to QSY tested were 1:10,000, 
1:25,000, 1:50,000, 1:75,000, and 1:100,000.  The ratios above 1:50,000 aggregated and 
therefore were not characterized further.  The 1:50,000 ratio of NP:QSY was studied 
using DLS measurements. The size and zeta potential were taken after each step to 
characterize successful loading of QSY onto IO-Au NPs (Table 3.4 using NOVs as an 
example).  After the addition of QSY the size increased by 1.2 nm and the zeta potential 
decreased by ~4 mV.  This is expected as the QSY molecules are slightly negatively 
charged.  After finding the optimal loading efficiency of NPs:QSY (1:50,000) without NP 
aggregation, this ratio was used for nanospheres, nanovals, and nanopins for a 
comparative study of their SERS properties.  After the IO-Au NPs were mixed with QSY, 
the NPs were then coated with mPEG-SH (1:50,000) for stabilization of the QSY 
adsorption via the Au-S covalent bond.  Table 3.4 shows that after the addition of mPEG-
SH the hydrodynamic size of the QSY-IO-NPs increased by ~ 15nm while the zeta 
potential decreased by ~ 17 mV.  This is expected as the size of the mPEG 5K is 
approximately 15-20 nm.  The decrease in zeta potential is due to the exchange of the 
positively charged CTAB with the mPEG-SH.  After reaction, the desired SERS NPs 








Table 3.4. Hydrodynamic Diameter (HD) and zeta potential () at each step of the 
synthesis of SERS tagged IO-Au NOVs. 
 Hydrodynamic size  (nm) Zeta Potential 
(mV) 
IO-Au NOVs 72.0  2.2 28.5  0.5 
QSY21/IO-Au NOVs 73.2  2.7 24.8  0.8 
mPEG/QSY21/IO-Au NOVs 88.1   1.5  7.8  1.2 
 
  
The SERS signals from all the NPs were collected at the same power and same 
concentration of core-shell NPs using a portable Raman spectrometer (Enwave). The 
concentration of the NPs was 0.1 nM., the power of the laser was 25mW and the 
integration time was 1 s. The excitation laser wavelength was 785 nm.  Figure 3.21 shows 
the SERS of QSY reporters from the IO-Au NSs. The QSY gave a strong peak around 
1496 cm
-1
, with the intensity around 1200 a.u. The pure QSY solution as high as 1 mM 
did not show any Raman signal (data not shown). This indicates that IO-Au NSs 
enhanced the Raman signals of QSY.   
The SERS signals from IO-Au NOVs and NPINs are shown in Figure 3.22. The 
peak intensity at 1496 cm
-1
 was 55,000 a.u. for NOVs and 40,000 a.u. for NPINs.  
Compared to the signal intensity (1200 a.u.) for NSs in Figure 3.21, the NOVs gave a 45 
times stronger SERS activity and the NPINs gave 33 times stronger SERS activity than 
NSs.  This indicates that the IO-Au NOVs and IO-Au NPINs are very promising for 
SERS-based molecular diagnosis. The strong peaks at 1333, 1584 and 1641 cm
-1
 are from 







Figure 3.21. SERS spectra of QSY 21 adsorbed onto IO-Au nanospheres (50-60 nm). The 
strongest peak at 1496 cm
-1
 is ~ 1200 counts.  Excitation wavelength: 785 nm; power: 25 
mW; NP concentration: 0.1 nM; acquisition time: 1 sec. 
 
 
Figure 3.22. SERS spectra of QSY 21 adsorbed on IO–Au NPINs (black), IO–Au NOVs 
(red). Excitation wavelength: 785 nm; power: 25 mW; NP concentration: 0.1 nM; 
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3.6 Photothermal properties of iron oxide-gold nanoparticles 
 PTT based on NIR-absorbing NPs has become a sought-after treatment in 
nanomedicine in the last decade.  NIR absorption is critical for in vivo imaging and 
therapy because of minimal light absorption by water and hemoglobin and the resulting 
optimal tissue penetration of the light in this region  Silica/gold nanoshells, gold nanorods 
(Au NRs),  gold nanocages and hollow gold nanospheres have been widely used for 
photothermal cancer therapy.
20
  However, these nanoparticles do not possess high 
resolution imaging modalities such as MRI which are essential for the identification of 
cancer and thus better treatments.  By incorporating a magnetic IO core inside the Au 
NPs, dual MRI/PTT will be possible with the single nanoparticles.  This led to the study 
of the photothermal properties of the IO-Au NPINs, NOVs and spheres.  For this study 
all particles had the same overall size of 50-60 nm, the same as the SERS experiment 
discussed above.  These sizes were chosen because they displayed optimum SERS 
signals while maintaining strong magnetic properties.  We examined the potency of the 
nanoparticles for photothermal therapy by irradiating the nanoparticle solutions (100 uL) 
with a NIR laser.  The NPs at specified concentration were exposed to the laser (= 808 
nm, beam diameter: 1 cm, power density 0.55 W/cm
2
) with stirring and the temperature 
of the solution was monitored using a hypodermic thermocouple for up to 8 minutes 
(Figure 3.23).  As is expected the IO-Au NSs (blue curve) did not cause heating with a 
NIR laser.  This is because the NSs absorb light from 530-560 nm and do not have any 
absorption in the NIR window.  The IO-Au NOVs cause heating with exposure to the 
NIR laser which is expected because they have slight absorption in the NIR region.  The 
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NPINs show the highest capability of heating up to 59
o
C.  This is due to the strong 
absorption in the NIR region (800 nm).    
 
 
Figure 3.23. Photothermal heating of IO-Au NPs upon exposure to a NIR laser.  IO-Au 
nanospheres (blue) show no significant heating.  The IO-Au NOVs (red) show heating up 
to ~44
o
C.  The NIR absorbing NPINs (green) show heating up to ~59
o
C. Laser 




 The IO-Au NPINs were further studied due to their excellent photothermal 
properties as shown in Figure 3.24.  Au Nanorods are well known for their bimodal 
absorption and strong absorption in the NIR region.  Au NRs are one of major 
photothermal contrast agents in cancer therapy.
26
  This led us to compare the 
photothermal properties of Au NRs and our IO-Au NPINs.  The temperature of a 0.01 
nM IO-Au NPIN solution increased rapidly within the first 3 min, followed by gradual 
elevation until reaching plateau around 59
o
C.  As a comparison, the Au NR solution at 





C.  To raise the temperature to a comparable value of the IO-Au NPINs, the 
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concentration of the rods has to be increased to 0.5 nM. Thus, the photothermal property 
of core-shell NPINs is approximately 50 times better than that of Au NRs, due to the 
much higher absorption coefficient of NPINs.  Such an efficient laser heating profile 
indicates the great potential of the new hybrid NPs for photothermal cancer therapy. 
Further experiments on the concentration dependence showed that the temperature is 
proportional to the concentration of the NPs (Figure 3.20). The NPINs of 0.005 nM and 






Figure 3.24. Photothermal properties of IO–Au NPINs. (A) Comparison of the  
photothermal effects of IO–Au NPINs and Au NRs; (B) concentration dependence of the 
photothermal effects of IO–Au NPINs. IO–Au NPs give similar heating profiles to Au 
NRs with 50 times higher molar concentrations. Laser wavelength: 808 nm; power 
density: 0.55 W cm 
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CHAPTER 4: CONCLUSIONS AND OUTLOOK 
 
 The work in this thesis focused on the synthesis of compact IO-Au core-shell NPs 
with facile tuning of the size and shape of the NPs using a seed mediated growth method.  
In addition to the synthesis of the NPs, the distinct properties from the IO core and IO-Au 
hybrid NPs were characterized.  The SERS activities and photothermal effects were 
investigated for each type of IO-Au NPs including NSs, NOVs and NPINs. 
 The IO-Au NSs showed facile tuning of the overall size ranging from 40 to 120 
nm.  The results from the absorption spectra showed that the IO-Au NSs exhibited a 
strong surface Plasmon resonance ascribed to the Au shell.  Furthermore, the IO-Au NSs 
show that they are responsive to an external magnetic field indicating the retention of the 
magnetic properties of the IO core. The SERS data shows that the SERS tagged NSs had 
a weak Raman intensity of ~ 1200 counts which is expected from the QSY21 Raman 
reporter that were nonspecifically adsorbed onto the NPs.  The NSs did not show any 
photothermal heating when irradiated with a NIR laser, which is expected due to the lack 
of NIR absorption of the NPs. 
 The synthesis of compact anisotropic IO-Au core-shell NPs still remains a major 
challenge today.  In this study we developed a simple method to synthesize anisotropic 
NPs by modifying the procedure for the synthesis of IO-Au NSs.  By simply adding 
AgNO3 to the growth solution, compact IO-Au NPs in oval shapes were formed.  The 
TEM showed that the NPs had a faceted oval shape.  The size of the NOVs was also 
easily tuned from 40 to 120 nm.  The size was precisely controlled by varying the amount 
of IO seed particles injected into the growth solution.  The results showed the IO-Au 
NOVs had a much stronger SERS effect than the NSs.  In fact, the NOVs had ~ 45 times 
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stronger SERS signals versus the spheres of the same overall size.  The IO-Au NOVs also 
showed photothermal heating once irradiated with a NIR laser.  After irradiation for 8 
minutes, the NP solution reached a temperature of approximately 44
o
C.  The NOVs were 
separated from the solution by an external magnet, indicating their good magnetic 
properties. Quantitative measurement showed that the NOVs are superparamagnetic, 
similar to their IO cores. Overall the IO-Au NOVs display excellent optical properties as 
well as magnetic properties.   
          In this thesis we have further made compact NIR absorbing IO–Au hybrid NPs in 
pin shapes by adjusting the AA concentration in the growth solution.  The size of the 
NPINs was tuned from 40 to 100 nm.  The NPINs display excellent photothermal 
properties due to their surface Plasmon resonance band the NIR region.  The results 
indicate that the NPIN solution can reach up to 59
o
C upon irradiation.  In fact, the 
photothermal property of the NPINs is approximately 50 times stronger than that of Au 
NRs which is due to the much higher absorption coefficient of NPINs.  The results also 
showed that the temperature is proportional to the concentration of the NPs.   The NPINs 
also exhibit excellent SERS properties as well.  The NPINs have ~ 33 times stronger 
signal of the same sized nanospheres.  The NPINs also displayed magnetic separation 
when placed against an external magnet. The compact NPINs also maintain the 
superparamagnetic properties of the IO core.  
 In future studies, we aim to use these NPs for cancer diagnostics and treatment.  
By using the facile surface chemistry of the Au shell one can conjugate tumor specific 
ligands for specific targeting of cancer cells.  These hybrid nanoparticles could allow for 
the isolation, detection and therapy of cancer cells. For SERS-based cancer detection, the 
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NOVs would be ideal due to their stronger SERS activities compared to the other two 
shapes. The NPINs would be ideal for MR imaging and photothermal cancer therapy due 
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